Directors. Bo Eklöf Peter Neglén Andrew Nicolaides. Organising Committee
|
|
|
- Alexandrina Wilkinson
- 5 years ago
- Views:
Transcription
1 5 th 2014 HANDS-ON WORKSHOP on VENOUS DISEASE Grand Resort, Limassol, Cyprus 30 Oct 1 Nov 2014 Education and hands-on practice for the benefit of patients with venous disease Directors Bo Eklöf Peter Neglén Andrew Nicolaides Organising Committee Bo Eklöf Peter Neglén Andrew Nicolaides Stephen Black Marzia Lugli Stylianos Papas Faculty Niels Baekgaard Haraldur Bjarnason Stephen Black Lena Blomgren Joseph Caprini Sylvain Chastanet Jan Christenson Alun Davies Marianne De Maeseneer Bo Eklöf Steve Elias Athanasios Giannoukas Maura Griffin Julian Hague Claudine Hamel Desnos Thomas Heller Lars Lönn Marzia Lugli Kent Lund Oscar Maleti Giovanni Mosti Peter Neglén Olle Nelzén Andrew Nicolaides Rickard Nyman Stylianos Papas Michel Perrin Lars Rasmussen Antonio Rosales Evgeny Shaidakov Iain Wilson Sponsors ACI Medical Angiodynamics Bauerfeind Bayer Biolitec BSCI BSN-Jobst BTG Circaid/Medi Germany Cook Medical Covidien Kreussler Lohmann & Rauscher Mentice Vascular Insights Veniti Volcano Contact: Anne Taft, European Venous Forum, Tel/Fax: +44 (0) admin@europeanvenousforum.org
2 PRELIMINARY SCIENTIFIC PROGRAMME Thursday 30 October Welcome Chronic Venous Disease (CVD) Moderator: Bo Eklöf Pathophysiology of CVD. Andrew Nicolaides (Cyprus) Clinical importance of classification of CVD. Bo Eklöf (Sweden) Venous hemodynamics (pressure, volume and flow changes). Andrew Nicolaides (Cyprus) How accurate are our tests for reflux and obstruction? Peter Neglén (Cyprus) Assessment of outcomes in CVD. Alun Davies (UK) Discussion Treatment of varicose veins Moderator: Peter Neglén Are drugs indicated and efficient? Michel Perrin (France) Stockings or bandages all the same? Giovanni Mosti (Italy) Discussion Coffee break Optimal technique of Ultrasound guided saphenous stripping and phlebectomy. Marzia Lugli (Italy) Saphenous laser ablation. Athanasios Giannoukas (Greece) Saphenous ablation by radio frequency devices. Marianne De Maeseneer (The Netherlands) Foam sclerotherapy. Claudine Hamel Desnos (France) Non-thermal saphenous ablation. Steve Elias (USA) Discussion When should we save the saphenous vein? Sylvain Chastanet (France) What does comparative studies on ablation techniques tell us? Lars Rasmussen (Denmark) Which method should you choose? Alun Davies (UK) Discussion The controversy of the perforators. Olle Nelzén (Sweden) Intervention for recurrence (PREVAIT). Marianne De Maeseneer (The Netherlands) Case presentations Lunch Moderator: Marzia Lugli Pelvic congestion syndrome. Marzia Lugli (Italy) Case presentations The importance of duplex scanning in CVI. Lena Blomgren (Sweden) How do I perform a duplex study? Kent Lund (Sweden)/ Stylianos Papas (Cyprus) Introduction to the Workshops Can simulation replace reality training? Lars Lönn (Denmark) Workshop when, where and how? Peter Neglén (Cyprus) Workshops: Organiser: Peter Neglén Duplex investigations, IVUS/Stenting, Saphenous ablation, Bandaging, Foamsclerotherapy,
3 Friday 31 October 2014 Acute Thromboembolism Moderator: Andrew Nicolaides Can we avoid the postthrombotic syndrome? Bo Eklöf (Sweden) Do recent guidelines for prevention of DVT affect your practice? Andrew Nicolaides (Cyprus) Will you treat acute DVT differently because of recent guidelines? Alun Davies (UK) Practical implication on treatment of superficial thrombophlebitis by guidelines. Athanasios Giannoukas (Greece) Discussion Duplex ultrasound scanning to diagnose acute DVT. Kent Lund (Sweden) How to perform a duplex study for acute DVT. Live demonstration. Maura Griffin (UK)/Stylianos Papas (Cyprus) CTV, MRV and venography in the venous workup (acute DVT and CVD). Rickard Nyman (Sweden) IVUS in acute and chronic venous disease. Stephen Black (UK) Coffee break. Treatment of Acute DVT Moderator: Stephen Black Conservative treatment of acute DVT. Joseph Caprini (USA) Does the new oral anticoagulants change the treatment of VTE? Andrew Nicolaides (Cyprus) Case presentations Catheter-directed thrombolysis. Niels Baekgaard (Denmark) Pharmacomechanical thrombectomy. Julian Hague (UK) The role of IVC filters. Ian Wilson (UK) Discussion Case presentations Lunch Workshops: Organiser: Peter Neglén Duplex investigations, IVUS/Stenting, Saphenous ablation, Bandaging, Foamsclerotherapy,
4 Saturday 1 November 2014 Diagnosis and treatment of chronic venous insufficiency (C3-C6) Moderator: Alun Davies Sequential treatment plan for CVI. Peter Neglén (Cyprus) Compression treatment of venous ulcers. Joseph Caprini (USA) Case presentations Compartment pressure and venous ulcers the role of fasciotomy. Jan Christenson (Switzerland) Treatment of deep vein obstruction. Haraldur Bjarnasson (USA) Case presentations Coffee break Valve repair in primary deep vein incompetence. Antonio Rosales (Norway) When to use the Vedensky spiral. Evgeny Shaydakov (Russia) Can we treat postthrombotic deep vein incompetence? Oscar Maleti (Italy) Discussion Case presentations Lunch How can I get the appropriate venous patients referred to me? Round Table Discussion. Moderator: Peter Neglén Stephen Black, Lena Blomgren, Joseph Caprini, Alun Davies, Antonio Rosales, Scott Solano, Building a multi-disciplinary team and reach out. Stephen Black (UK) The role of the industry. Scott Solano (USA) Discussion Workshops: Organiser: Peter Neglén Duplex investigations, IVUS/Stenting, Saphenous ablation, Bandaging, Foamsclerotherapy, Gala Dinner
5 WORKSHOP Thursday 30 October : Introduction of workshops by Peter Neglén. 15 min between each workshop Duration of each workshop is 1h55mins. Each workshop contains 4 stations, i.e. 25 min/station. Each group will consist of 20 participants with 5 participants/station Workshop: Station 1-25min, change -5min, Station 2-25min, change -5min, Station 3-25min, change -5min, Station 4-25min = 1 hours 55min Attendance Card signed by each workshop to receive end of course Diploma Rotation schedule Thursday 30 October Friday 31 October Saturday 1November Workshop Group Group Group Group Group Group 1 A F E D C B 2 B A F E D C 3 C B A F E D 4 D C B A F E 5 E D C B A F 6 F E D C B A Workshop 1 Workshop 2 Station 1. Normal findings Station 2. Abdominal and Pelvic Station 3. Superficial Incompetence Station 4. Deep Incompetence Station 1. Stent (Veniti) Station 2. IVC filter (Cook Medical) Station 3. Ulcer treatment (BSN Jobst) Station 4. Trellis (Covidien) Workshop 3 Workshop 4 Station 1. Laser (Biolitec) Station 2. Stocking (Bauerfeind) Station 3. CDT (BTG - EKOS) Station 4. Foam Sclerotherapy (Kreussler) Station 1. IVC filter (Volcano) Station 2. RFA (Covidien) Station 3. Bandage (Lohmann & Rauscher) Station 4. CircAid bandage (Medi) Workshop 5 Workshop 6 Station 1. Simulator (Mentice) Station 2. Stent (Boston Scientific) Station 3. Clarivein (Vascular Insights) Station 4. IVUS (Volcano) Station 1. Angiojet (Bayer Healthcare) Station 2. CDT (Angiodynamics) Station 3. Valve repair Station 4. APG (ACI Medical)
SCIENTIFIC PROGRAMME
9 th EVF HOW HANDS-ON WORKSHOP on VENOUS DISEASE Grand Resort, Limassol, Cyprus, 25-27 October 2018 SCIENTIFIC PROGRAMME Thursday 25 October 2018 07.30 Welcome Chronic Venous Disease (CVD) - Basics 07.45
Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden
Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Disclosures No disclosures Five sources for comparison SVS/AVF US guidelines
Pharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus
Pharmaco-mechanical techniques stand alone procedures? Peter Neglén, MD, PhD SP Vascular Center Limassol Cyprus Faculty Disclosure Peter Neglén, M.D., Ph.D Stockholder/Founder of Veniti, Inc. Member, Medical
LIVE DEMONSTRATION IN-OFFICE WORKSHOP SUMMIT IN PHLEBOLOGY
PRELIMINARY PROGRAM LIVE DEMONSTRATION IN-OFFICE WORKSHOP SUMMIT IN PHLEBOLOGY KELOWNA, BC, CANADA, APRIL 27-28-29, 2012 PROGRAM CO-CHAIRMEN Janna Bentley, Kelowna, BC, Canada Pauline Raymond-Martimbeau,
On Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View
On Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View Peter Gloviczki, MD Ying Huang, MD, PhD Division of Vascular and Endovascular Surgery, Mayo
Improved clinical outcomes Evidence on venous thrombectomy followed by stenting
Improved clinical outcomes Evidence on venous thrombectomy followed by stenting Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany Venous Centre Arnsberg, Germany Disclosure Speaker
HANDS-ON WORKSHOP on VENOUS DISEASE Holiday Inn Hotel, Krakow, Poland October 2017
8 th 2017 HANDS-ON WORKSHOP on VENOUS DISEASE Holiday Inn Hotel, Krakow, Poland 26 28 October 2017 Directors Stephen Black Marianne De Maeseneer Marzia Lugli Andrew Nicolaides Tomasz Urbanek Faculty Niels
New Guideline in venous ulcer treatment: dressing, medication, intervention
New Guideline in venous ulcer treatment: dressing, medication, intervention Kittipan Rerkasem, FRCS(T), PhD Department of Surgery Faculty of Medicine Chiang Mai University Topic Overview venous ulcer treatment
THERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT
THERE IS NO ROLE FOR SURGICAL THERAPY FOR DVT Tara D. Balint, MD FACS Sentara RMH Thursday, June 14, 2018 1 Objectives of treatment for DVT Prevent death from PE Prevent recurrent VTE Prevent post-thrombotic
14 th Annual meeting of the European Venous Forum, in collaboration with the Balkan Venous Forum and the Serbian College of Phlebology
14 th Annual meeting of the European Venous Forum, in collaboration with the Balkan Venous Forum and the Serbian College of Phlebology Thursday 27 th June Sunday 30 th June 2013 PROVISIONAL PROGRAMME THURSDAY
in collaboration with
in collaboration with MEETING DIRECTORS: N. Labropoulos, D. Kontothanassis SCIENTIFIC SECRETARIAT: G. Camporese, A. Gasparis ORGANIZING SECRETARIAT T&C via San Gregorio, 12 20124 Milano tel. 02/29534181
How to best approach chronic venous occlusions?
How to best approach chronic venous occlusions? Prof. Nils Kucher Director Venous Thromboembolism Reseach Group University Hospital Bern nilskucher.com Disclosure Speaker name: Nils Kucher X X I have the
Vein Disease Treatment
MP9241 Covered Service: Yes when meets criteria below Prior Authorization Required: Yes as indicated in 2.0, 3.0, 4.0 and 5.0 Additional Information: None Prevea360 Health Plan Medical Policy: Vein disease
Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL
Venous Disease and Leg Ulcers Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Disclosures Stocks Endoshape Sapheon Medical Advisory Board BTG, Boston Scientific Venous Leg Ulcer Most common
2017 Florida Vascular Society
Current Management of Venous Leg Ulcers: How to Identify Patients with Correctable Venous Disease and Interventional Procedures to Heal and Prevent Recurrence 2017 Florida Vascular Society Bill Marston
The evidence for venous interventions is evolving- many patients do actually benefit. Nils Kucher University Hospital Bern Switzerland
The evidence for venous interventions is evolving- many patients do actually benefit Nils Kucher University Hospital Bern Switzerland Disclosure Speaker name: Nils Kucher X X I have the following potential
Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC
Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label
Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results
Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guy s and St Thomas
Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?
Clinical/Duplex Evaluation of Varicose Veins: Who to Treat? Sanjoy Kundu MD, FASA, FCIRSE, FSIR The Vein Institute of Toronto Scarborough Vascular Group Scarborough Vascular Ultrasound Scarborough Vascular
Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center
Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction Erin H. Murphy, MD Rane Center Disclosure Speaker name: Erin H. Murphy... I have the following potential conflicts
How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.
How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN Surgeon Dr G Mark Malouf Sydney Australia Following History and Physical examination
Conflict of Interest. None
Conflict of Interest None American Venous Forum Guidelines on Superficial Venous Disease TOP 10 GUIDELINES 10. We recommend using the CEAP classification to describe chronic venous disorders. (GRADE 1B)
Improved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting
Improved clinical outcomes Evidence on venous mechanical thrombectomy followed by stenting Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany German Venous Centre Arnsberg, Germany Disclosure
Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015
Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Anatomy of Perforating veins Cadaveric studies 1 have shown >60 vein perforating veins from superficial to deep Normal
Techniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT
Techniques for thrombus removal in acute DVT Benefits of an Endovascular Approach for Rapid Flow Restoration in DVT Michael K. W. Lichtenberg, MD, FESC Vascular Centre Arnsberg, Germany Disclosure Speaker
Selection and work up for the right patients suspected of deep venous disease
Selection and work up for the right patients suspected of deep venous disease R A G H U K O L L U R I, M S, M D, R V T S Y S T E M M E D I C A L D I R E C T O R V A S C U L A R M E D I C I N E / V A S
Donnees physiopathologiques dans l IVC, limites OSCAR MALETI
Donnees physiopathologiques dans l IVC, limites OSCAR MALETI President of Italian College of Phlebology Vice-President of European Board of Phlebology (UEMS) Chief of Vascular Surgery CardioVascular Surgery
TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY
TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TL LUK Consultant Vascular Surgeon Sarawak General Hospital HKL Vascular Conference 19/06/2013 PREVALENCE OF LOWER LIMB VENOUS DISEASE Affects half of
Le varici recidive Recurrent varices: how to manage them?
Le varici recidive Recurrent varices: how to manage them? Marianne De Maeseneer MD PhD, Vascular Surgeon Department of Dermatology, Rotterdam, Netherlands & Faculty of Medicine and Health Sciences University
The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study
The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency A Prospective, Multi-centre Study Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor
Current Management of C0s patient
Current Management of C0s patient M. Perrin Vascular Surgery, Lyon, France 1 AIM of the PRESENTATION - 1 st to estimate the prevalence of C 0s patient - 2 d to evaluate its current management - 3d to suggest
Current Management of Varicose Veins
Current Management of Varicose Veins Michael J. Heidenreich, MD St. Joseph Mercy Hospital Ann Arbor, MI March 23, 2013 Nothing to disclose History Prevalence Anatomy Risk factors Clinical manifestations
Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach
Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Prof. I. Baumgartner Head Clinical and Interventional Angiology About the ACCP guidelines Widely
Patient assessment and strategy making for endovenous treatment
Patient assessment and strategy making for endovenous treatment Raghu Kolluri, MD Director Vascular Medicine OhioHealth Riverside Methodist Hospital Columbus, OH Disclosures Current Medtronic Consultant/
Should We Be More Aggressive in the Treatment of Acute DVT?
DISCLOSURES Consultant Penumbra, Inc. UCSF Vascular Surgery Symposium April 6, 2017 K. Pallav Kolli, MD Assistant Professor of Clinical Radiology University of California, San Francisco 17 yo male, DVT
Venous interventions in DVT
Venous interventions in DVT Sriram Narayanan Chief of Vascular and Endovascular Surgery, Tan Tock Seng Hospital A/Prof of Surgery, National University of Singapore ANTI-COAGULATION LMWH Warfarin x 6m Acute
Benelux Society of Phlebology
Benelux Society of Phlebology Lymphedema, leg ulcers and compression therapy Annual meeting June 1-3, 2017 In cooperation with the Dutch College of Phlebology (DCoP) 29 en NH 30 Gent/Gand mei 2015 Belfort,
Treatment of Varicose Veins
Treatment of Varicose Veins Policy Number: Original Effective Date: MM.06.016 04/15/2005 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 09/28/2018 Section: Surgery Place(s) of
Chronic Venous Insufficiency Compression and Beyond
Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial
CME/CE SUPPLEMENT, PROGRAM ERRATA & ADDENDUM
American College of Phlebology 31 st Annual Congress November 2 5, Austin, Texas CME/CE SUPPLEMENT, PROGRAM ERRATA & ADDENDUM EDUCATIONAL GRANT SUPPORT The American College of Phlebology (ACP) gratefully
Venous stenting in Marseille
Venous stenting in Marseille Olivier HARTUNG, MD, MSc CHU Nord, Marseille, FRANCE Disclosure Speaker name: Olivier HARTUNG I have the following potential conflicts of interest to report: x Consulting :
Compression after sclerotherapy and endovenous ablations, the Italian point of view
Compression after sclerotherapy and endovenous ablations, the Italian point of view Fabrizio Mariani Siena (Italy) General Secretary "Multidisciplinary Joint Committee in Phlebology" - UEMS (EU) General
Features compression after open and endovascular operation in vascular malformation
Features compression after open and endovascular operation in vascular malformation Sapelkin Sergey Institute of Surgery named A.V. Vishnevsky, Moscow, Russia 21.10.2017 CIRC Meeting, Grassau AV-malformations:
A Successful External Valvuloplasty By Banding Application
ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 13 Number 2 A Successful External Valvuloplasty By Banding Application U Yetkin, C Özbek, M Akyüz, S Bayrak,? Yürekli, A Gürbüz
The role of ultrasound duplex in endovenous procedures
The role of ultrasound duplex in endovenous procedures Neophytos A. Zambas MD, PhD Vascular Surgeon Polyclinic Ygia, Limassol, Cyprus ΚΕΑΕΧ ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΑΓΓΕΙΑΚΗΣ ΚΑΙ ΕΝΔΑΓΓΕΙΑΚΗΣ ΧΕΙΡΟΥΡΓΙΚΗΣ Pre
Event: Sonographic Examination of the Rotator Cuff Tendons 2. Event: Duplex Examination of Carotid Arteries 3
These workshops are offered to sonographers or physicians who wish to upgrade their scanning skills in order to perform ultrasound examinations with confidence and efficiency. We currently register applicants
The role of new reflux of accessory veins in clinical recurrence of varicose veins after endovascular laser ablation (EVLA)
Cyprus Society of Vascular and Endovascular Surgery The role of new reflux of accessory veins in clinical recurrence of varicose veins after endovascular laser ablation (EVLA) Toursidis Achilleas, MD,
A short review of diagnosis and compression therapy of chronic venous. insufficiency, Clinical picture and diagnosis A B S T R A C T WORDS
A short review of diagnosis and compression therapy of chronic venous insufficiency N. Kecelj Leskovec, M. D. Pavlovi}, and T. Lunder A B S T R A C T Introduction: Chronic venous insufficiency (CVI) is
Description and Management of C0s patient. M. Perrin, Vascular Surgery, Lyon, France
Description and Management of C0s patient M. Perrin, Vascular Surgery, Lyon, France 1 No disclosure of interest to declare for this presentation 2 AIM of the PRESENTATION 1 st to estimate the prevalence
Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO
Non-Saphenous Vein Treatments Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO I have no financial disclosures Types of Veins Treated Perforator Veins Tributary Veins Varicose
Techniques and Specific Treatment Modalities for the Active Non-Healing Wound. Luke Maj, MD, MHA
Techniques and Specific Treatment Modalities for the Active Non-Healing Wound Luke Maj, MD, MHA Assistant Professor of Radiology University of Miami, Miller School of Medicine Director of The Vein Center
Interventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
VENOUS SYMPOSIUM: OVERVIEW
1 VENOUS SYMPOSIUM: OVERVIEW Robert W. Vorhies, M.D., F.A.C.S. Vascular and Endovascular Surgery Endovenous Therapy and Vein Aesthetics Ferrell-Duncan Clinic, Cox Health Systems WHY DO WE CARE? Epidemiology
Copy Here. The Easy One.. What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Deep Venous Thrombosis Spectrum
What is the Role of Thrombus Removal in Acute Proximal DVT after ATTRACT? Mitchell J. Silver DO FACC FSVM RPVI Director, Center for Critical Limb Care Riverside Methodist Hospital Ohio Health Heart and
Priorities Forum Statement
Priorities Forum Statement Number 9 Subject Varicose Vein Surgery Date of decision September 2014 Date refreshed March 2017 Date of review September 2018 Relevant OPCS codes: L841-46, L848-49, L851-53,
Epidemiology: Prevalence
Epidemiology: Prevalence More than 30 million Americans suffer from varicose veins or a more serious form of venous disease called Chronic Venous Insufficiency (CVI). 1 Of the over 30 million Americans
Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.
Management of Venous Disease: an evidence based approach Disclosures Ed Boyle, MD Andrew Jones, MD Dr. Ed Boyle and Dr. Andrew Jones disclose Grants/research support: Medtronic, BTG International, Clearflow,
Venous Ulcers. A Little Basic Science. An Aggressive Prescription to Aid Healing. Why do venous ulcers occur? Ambulatory venous hypertension!
UCSF Vascular Symposium April 26-28, 2012 San Francisco, California True statements about the management of venous ulcers include: An Aggressive Prescription to Aid Healing Anthony J. Comerota, MD, FACS,
Efficacy of Velcro Band Devices in Venous and. Mixed Arterio-Venous Patients
Efficacy of Velcro Band Devices in Venous and Mixed Arterio-Venous Patients T. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery Martha-Maria Hospital
Additional Information S-55
Additional Information S-55 Network providers are encouraged, but not required to participate in the on-line American Venous Forum Registry (AVR) - The First National Registry for the Treatment of Varicose
Management of Post-Thrombotic Syndrome
Management of Post-Thrombotic Syndrome Thanainit Chotanaphuti Phramongkutklao College of Medicine Bangkok, Thailand President of CAOS Asia President of Thai Hip & Knee Society President of ASEAN Arthroplasty
Medicare C/D Medical Coverage Policy
Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: February 15, 2017 Next Review: February, 2019 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins
Verification of Participation & Certificate Request 29 th Annual Congress Orlando, Florida November 12 15, 2015
Complete this form in its entirety to claim the credits commensurate with your participation at the ACP s 29 th Annual Congress. You can only claim credit for one session if it runs concurrently with others.
UNDERSTANDING VEIN PROBLEMS
UNDERSTANDING VEIN PROBLEMS Varicose Veins, Chronic Venous Insufficiency, and DVT Do You Have a Vein Problem? Have you noticed pain or swelling in your legs? Do your symptoms worsen when you re sitting
EUROPEAN TRAINING REQUIREMENTS in PHLEBOLOGY
EUROPEAN TRAINING REQUIREMENTS in PHLEBOLOGY Fabrizio Mariani Siena (Italy) General Secretary Multidisciplinary Joint Committee in Phlebology - UEMS (EU) General Secretary European Board of Phlebology
Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:
E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your
pressure of compression stockings matters (clinical importance of pressure)
Classification of Compression Stockings ICC Meeting, Copenhagen, May 17, 2013. pressure of compression stockings matters (clinical importance of pressure) Giovanni Mosti; Lucca, Italy disclosure no conflict
Deep Venous Pathology. Eberhard Rabe Department of Dermatology University of Bonn Germany
Deep Venous Pathology Eberhard Rabe Department of Dermatology University of Bonn Germany Disclosures None for this presentation Consultant: Sigvaris, EUROCOM Speakers bureau: Bayer Vital, Aspen, Boehringer,
A one stop vein shop: the ideal option?
A one stop vein shop: the ideal option? Professor Alun H Davies Section of Vascular Surgery Imperial College, Charing Cross & St Mary s Hospitals London Conflicts of Interest None to declare Which treatment?
Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA
Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA DISCLOSURES Kathleen Gibson, MD Consultant/Advisory Board: BTG, Medtronic Speakers
Aggressive endovascular management of ilio-femoral DVT. thrombotic syndrome. is the key in preventing post
CACVS 2017 Aggressive endovascular management of ilio-femoral DVT is the key in preventing post thrombotic syndrome ALI AMIN MD, FACS,FACC, RVT CHIEF OF ENDOVASCULAR INTERVENTIONS READING HEALTH SYSTEM
Chronic Venous Disease: A Complex Disorder. A N Nicolaides
Chronic Venous Disease: A Complex Disorder A N Nicolaides Emeritus Professor of Vascular Surgery, Imperial College, London. Hon. Professor of Surgery, University of Nicosia Medical School, Cyprus Disclosures
SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS
SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS Michel M.P.J. Reijnen, M.D., Ph.D. Jean-Paul P.M. de Vries, M.D., Ph.D. Rijnstate Hospital, Arnhem, The Netherlands
ACP Phlebology Fellowship Curriculum 1
ACP Phlebology Fellowship Curriculum 1 There are seven columns in the curriculum outline 1. Goals and objectives (G & O)- curriculum objectives are listed in this column. 2. Resources- text references
Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:
Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Meissner MH, Gloviczki P, Comerota AJ,
Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.
Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal
Why Tumescent-Free Therapy Will Replace RF and Laser
C SCOTT MCENROE Medical Director Vein Center of Virginia Sentara Medical Group April 27, 2018 Why Tumescent-Free Therapy Will Replace RF and Laser History of Venous Surgery 1950 s GSV/SSV stripping became
Attendees enjoy the icon 2014 opening reception. evening, sponsored by the American Society of Cardiovascular Phlebologists (ASCVP).
Sunday, February 9 Physicians in Training Course Kicks off icon 2014 Attendees enjoy the icon 2014 opening reception on Sunday evening, sponsored by the American Society of Cardiovascular Phlebologists
Approve Date: 10/20/2014 Revise Dates: 04/21/2016 Next Review: 10/20/2016 Review Dates: 10/20/2015
Policy Number: 1025 Policy History Approve Date: 10/20/2014 Revise Dates: 04/21/2016 Next Review: 10/20/2016 Review Dates: 10/20/2015 Preauthorization All Plans Benefit plans vary in coverage and some
Percutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience
JFICV 2018, Beaune Percutaneous Mechanical Thrombectomy for Acute Iliofemoral DVT with the Aspirex Catheter: The Dijon Experience Prof. Romaric LOFFROY, MD, PhD, FCIRSE Chief, Department of Vascular and
EXTERNAL VALVULOPLASTY
Preservation of Saphenous Trunks: EXTERNAL VALVULOPLASTY Sante Camilli MD Rome, Italy sante.camilli@gmail.com Faculty disclosure Sante Camilli MD I am the proposer of the Stretching Valvuloplasty technique,
Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient
Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient T. Noppeney, J. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery
Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany
Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany Liquid Foam or GSV, foam / liquid sclerosant n diameter[mm] Follow up effectivity Hamel Desnos 2003
Recurrent Varicose Veins We All See Them
We All See Them November 4, 2017 Austin, TX Arlington Heights, IL No conflicts Terminology REVAS REcurrent Varices After Surgery PREVAIT PREsence of Varices After Interventional Treatment Recurrent varices
Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:
E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your
COMMISSIONING POLICY
Ref No. 1a7.5 COMMISSIONING POLICY Surgery for venous disease of the leg (Varicosities of the Long Saphenous Vein) April 2011 CONTENTS Section Page Summary 2 1. Background 2 2. Criteria for eligibility
RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY Paul Kramer, MD, FACC, FSCAI Liberty Cardiovascular Specialists Liberty Regional Heart and Vascular Center DISCLOSURES NONE Venous
UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only
UNDERSTANDING VEIN DISEASE UC201706537 EN - For use in the U.S. only Do you need to sit down during your work day because your legs ache and/or swell? Do you miss out on doing the activities you love because
Pioneers in venous surgery
Pioneers in venous surgery THE HOME OF KEYHOLE VARICOSE VEIN SURGERY thewhiteleyclinic.co.uk ONE CHAPEL PLACE LONDON W1 about us at the forefront The Whiteley Clinic introduced non-surgical varicose vein
Chronic Swelling, Pain, and Ulceration in the Left Lower Extremity
WHAT WOULD YOU DO? Chronic Swelling, Pain, and Ulceration in the Left Lower Extremity MODERATOR: BROOKE SPENCER, MD, FSIR PANEL: LAWRENCE RUSTY HOFMANN, MD; MARK J. GARCIA, MD, FSIR, FACR; AND BRENT T.
PROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES TREATMENT OF VARICOSE VEINS OF THE LOWER EXTREMITIES STAB PHLEBECTOMY AND SCLEROTHERAPY TREATMENT The primary purpose of this document is to assist providers enrolled in
Surgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine
Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &
A treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN
A treatment option for varicose veins. enefit" Targeted Endovenous Therapy Formerly known as the VNUS Closure procedure E 3 COVIDIEN THE VENOUS SYSTEM ANATOMY The venous system is made up of a network
OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009
OHTAC Recommendation Endovascular Laser Treatment for Varicose Veins Presented to the Ontario Health Technology Advisory Committee in November 2009 April 2010 Issue Background The Ontario Health Technology
Determine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient.
Patient Assessment :Venous History, Examination and Introduction to Doppler and PPG Dr Louis Loizou The 11 th Annual Scientific Meeting and Workshops of the Australasian College of Phlebology Tuesday 18
Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011
Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011 1. Treatment of ileofemoral venous occlusive disease: clinical experience M. de Wolf, MD 1 ; J. Grommes, MD 2 ; C. Arnoldussen, MD 3 ; R.
chronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis, Klippel- Trenaunay syndrome DVT CVD
Online publication August 27, 2009 chronic venous disorders: CVD CEAP 4 CEAP CVD J Jpn Coll Angiol, 2009, 49: 201 205 chronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis,
Treatment of telangiectasias by. foam sclerotherapy? under. ultrasound guidance. How to ensure the success of. 10 rules to respect
How to ensure the success of foam sclerotherapy? under 10 rules to respect Treatment of telangiectasias by ultrasound guidance Claudine Claudine Hamel-Desnos MD Hôpital Privé Caen- Saint France Martin
The Management of Stasis Dermatitis and Chronic Venous Insufficiency in Patients Refractory to Conservative Therapies
Article The Management of Stasis Dermatitis and Chronic Venous Insufficiency in Patients Refractory to Conservative Therapies Kareem Halim, 1,2, * Mark J. McElroy, 1 and John A. Lewis 3 1 Havard Medical
FACULTY MEMBERS. Joshua A. Beckman, MD Program Director The Brown Family Fellowship in Vascular Medicine Vanderbilt University Medical Center
2017-2018 FACULTY MEMBERS Joshua A. Beckman, MD Program Director The Brown Family Fellowship in Vascular Medicine Vanderbilt University Medical Center Vascular Medicine Joshua A. Beckman, MD Esther Kim,